StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SIVES.XC$59.05-8.31%
Fair $59.05+0.0%

SIVES.XC

SIVES.XC

Technology / SemiconductorsCboe UK

$59.05

-5.35 (-8.31%)

Fairly Valued+0.0%Fair Value $59.05Fund rank 30/100 · Data gapFallback financials|
SA 33/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 22%

FCF escenarios

weak_data · normalized FCF $-105.7M · quality 64.0/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 28/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

33/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -23.4%, below the 5% threshold
Thesis & Journal · SIVES.XCLocal privado en este navegador · SIVES.XC
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$17.5B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-23.4%

↓

Gross Margin

-0.7%

↓

Debt/Equity

0.13

↓
52-Week Range$59
$3$88

TradingView lightweight chart

SIVES.XC price, volumen y niveles de valoración

Último $59.05Periodo +1245.1%
Fair value: $59.05

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+32.2%

FCF CAGR

—

FCF margin

-34.5%

FCF / Net income

0.47x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $306.6M · net income $-222.6M · FCF $-105.7M

2022-FY → 2025-FY

Gross margin

-0.7%-108.5% pts

Operating margin

-58.0%+81.6% pts

Net margin

-72.6%-7.5% pts

FCF margin

-34.5%+133.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$306.6M$306.6M$219.2M$236.3M$132.6M
Net Income$-222.6M$-222.6M$-183.9M$-157.4M$-86.4M
EBITDA$-138.9M$-138.9M$-80.4M$-32.7M$14.1M
EPS——-0.78-0.68-0.41
Gross Margin-0.7%-0.7%1.9%96.1%107.8%
Operating Margin-58.0%-58.0%-88.6%-67.1%-139.6%
Net Margin-72.6%-72.6%-83.9%-66.6%-65.1%
Balance Sheet
Debt/Equity0.130.130.150.080.07
Current Ratio1.501.50———
Cash Flow
Free Cash Flow$-105.7M$-105.7M$-90.5M$-159.7M$-222.5M
Returns
ROE-23.4%-23.4%-16.9%-13.4%-7.0%
Valuation
P/B18.4418.44———
Growth & Yield
Revenue Growth39.8%39.8%-7.2%78.2%—
EPS Growth——-14.7%-65.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total +1245.1%

Total return

+1245.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.78 → n/d

Residual

+1245.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+1245.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.